FAQ: Izotropic's IzoView Breast CT Imaging System - Next-Generation Breast Cancer Detection Technology
Summary
Izotropic Corporation has unveiled its IzoView Breast CT Imaging System, a revolutionary platform that transforms breast cancer screening by providing 360-degree 3D visualization without compression discomfort, overcoming limitations of traditional mammography especially for dense breast tissue.
What is the IzoView Breast CT Imaging System?
The IzoView Breast CT Imaging System is Izotropic’s flagship next-generation technology for breast cancer screening that provides true 360-degree, 3D visualization without compression discomfort, designed to overcome limitations of traditional mammography.
How does IzoView differ from traditional mammography?
Unlike compression-based 2D imaging used in traditional mammography, IzoView delivers 360-degree 3D visualization without discomfort and provides clearer detection in dense breast tissue where lesions are often obscured in standard scans.
What are the key technical advantages of the IzoView system?
The system features a rapid 10-second scan time, high spatial resolution that surpasses MRI, radiation levels comparable to conventional mammography, and a self-shielding design that eliminates the need for facility retrofits.
Why is this technology particularly important for dense breast tissue?
Dense breast tissue often obscures lesions in standard mammography scans, but IzoView’s 360-degree 3D visualization enables clearer detection specifically addressing this long-standing limitation in breast cancer screening.
How does IzoView benefit healthcare providers and facilities?
The system is built as a scalable platform that supports future software-driven clinical applications from screening to treatment monitoring, maximizing ROI while its self-shielding design expands accessibility across diverse imaging environments without requiring facility retrofits.
What company is behind the IzoView technology?
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) is leading the development of this breast cancer screening transformation technology.
Where can I find more information about Izotropic Corporation?
More information can be found on the company’s website at izocorp.com and by reviewing its profile on SEDAR at sedarplus.ca.
What are the patient benefits of using IzoView compared to traditional methods?
Patients benefit from enhanced safety with radiation levels comparable to conventional mammography, improved comfort without compression, and clearer detection capabilities especially for those with dense breast tissue.
How does the IzoView platform support future clinical applications?
Built as a scalable platform, IzoView supports future software-driven clinical applications ranging from screening to treatment monitoring, allowing for expanded functionality over time.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 257066